Skip to main content
. 2011 Nov 1;15(9):2543–2563. doi: 10.1089/ars.2011.3965

FIG. 4.

FIG. 4.

Hypothesized pathways for doxorubicin-induced weakness in skeletal muscle. Illustration depicts the two proposed mediators, ROS and TNF, along with hypothesized downstream signaling involved in mediating muscle weakness caused by doxorubicin. ROS, reactive oxygen species; TNF, tumor necrosis factor-alpha; TNFR1, TNF receptor subtype 1.